Boston Scientific Corporation has been experiencing a period of significant activity. Multiple investment firms have adjusted their stock holdings in **Boston Scientific Corp (BSX)**, such as **Atria Investments Inc**, which purchased over 35,000 shares, and **Public Sector Pension Investment Board**, adding over 900,000 to their order book. Certain entities, such as **Freemont Management S.A.** and **Phoenix Financial Ltd.**, have reduced their positions. On the other hand, **Longbow Finance SA** and **Impax Asset Management Group plc** have been increasing their holdings. The company has reported **mixed Q4 2025 results** and a cautious **2026 growth outlook**, resulting in share price fluctuations leaving investors mixed on whether to buy, hold, or sell. Boston Scientific plans to participate in **TD Cowen's 46th Annual Health Care Conference**. They've also recently agreed to acquire **Penumbra, Inc.**, and completed the purchase of **Nalu Medical**. With the backdrop of a securities fraud investigation being conducted by Levi & Korsinsky, the turbulence reflected in the stock price, sees a range of views among market analysts.
Boston Scientific Corp BSX News Analytics from Mon, 15 Sep 2025 07:00:00 GMT to Sat, 14 Feb 2026 08:30:03 GMT -
Rating -2
- Innovation 3
- Information 7
- Rumor -1
